The Cooper Compan…
USUSDThe Cooper Companies, Inc (US:COO) — Ophthalmic Goods. Biržu skaits, kurās tiek tirgotas uzņēmuma akcijas: 4. Šajā lapā — cena un grafiks, dividendes, lielākie akcionāri un akciju skaita vēsture.
- The Cooper Companies Inc. — COO · MX MX reģistrācijas numurs nav zināms
Par uzņēmumu
- Tīmekļvietne
- coopercos.com
- Investoru attiecības
- investor.coopercos.com/
- Nozare
- Health Care · Ophthalmic Goods
- Galvenā mītne
- SAN RAMON, United States
- Izpilddirektors
- Mr. Albert G. White III
- Darbinieki
- 15 000
- Dibināts
- 1958
- Apgrozībā esošās akcijas
- 190.16 milj. uz 2026-09-03
- Brīvā apgrozība
- 188.77 milj.
- Tirgus kapitalizācija
- 10.77 mljrd. USD
- Iekšējās personas
- 0.63%
- Institucionālie investori
- 111.92%
- Nozare (SIC)
- Ophthalmic Goods
- Juridiskā forma
- XTIQ
- ISIN
- US2166484020
- LEI
- QJKMVPIGLH7530PCUE20
Apraksts
The Cooper Companies, Inc., together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment offers spherical, toric, and multifocal contact lenses that address vision challenges, such as astigmatism, presbyopia, and myopia. Its CooperSurgical segment focuses on family and women's health care, which provides fertility products and services, medical devices, and contraception, as well as cryostorage, such as cord blood and cord tissue storage. This segment offers Paragard, a hormone-free intrauterine device; and fertility consumables and equipment, donor gamete services, and genomic services, including genetic testing. The company sells its products to distributors, group purchasing organizations, eye care and health care professionals, including independent practices, corporate retailers, hospitals and clinics, and authorized resellers. The Cooper Companies, Inc. was founded in 1958 and is headquartered in San Ramon, California.
Dividendes
| Ex-datums | Izmaksa | Summa | % | Veids | Tikeris |
|---|---|---|---|---|---|
| 2023-07-26 | — | 0.0300 USD | 0.1/0.1 % | — | LSE:0I3I |
Ziņas šonedēļ
Pēdējās nedēļas laikā nav ziņu. Jaunākās ziņas: 20.07.2026.
Lielākie akcionāri
| Turētājs | Daļa | Akcijas | Pārskata datums |
|---|---|---|---|
| Blackrock Inc. | 7.9% | 15.03 milj. | 2026-06-30 |
| Vanguard Capital Managem… | 6.71% | 12.76 milj. | 2026-06-30 |
| State Street Corporation | 4.68% | 8.89 milj. | 2026-06-30 |
| Vanguard Portfolio Manag… | 4.56% | 8.67 milj. | 2026-06-30 |
| T. Rowe Price Investment… | 3.91% | 7.43 milj. | 2026-06-30 |
| Browning West Lp | 3.78% | 7.2 milj. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 3.26% | 6.19 milj. | 2026-06-30 |
| Price (T.Rowe) Associate… | 2.93% | 5.58 milj. | 2026-06-30 |
| Kayne Anderson Rudnick I… | 2.86% | 5.43 milj. | 2026-06-30 |
| Geode Capital Management… | 2.82% | 5.36 milj. | 2026-06-30 |
| Franklin Resources, Inc. | 2.68% | 5.1 milj. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.66% | 5.06 milj. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 2.35% | 4.47 milj. | 2026-06-30 |
| T. Rowe Price Mid-Cap Gr… | 2.04% | 3.88 milj. | 2026-06-30 |
| VANGUARD INDEX FUNDS-Van… | 1.49% | 2.83 milj. | 2026-06-30 |
| Invesco Exchange-Traded… | 1.47% | 2.79 milj. | 2026-08-31 |
| T. Rowe Price Mid-Cap Va… | 1.45% | 2.76 milj. | 2026-06-30 |
| iShares Trust-iShares Co… | 1.37% | 2.6 milj. | 2026-08-31 |
| JANUS INVESTMENT FUND-Ja… | 1.33% | 2.52 milj. | 2026-06-30 |
| Fidelity Concord Street… | 1.33% | 2.52 milj. | 2026-07-31 |
| WEISS ROBERT S (Director… | ≈0.29% | 550 459 | 2026-04-01 |
| WHITE ALBERT G III (Chie… | ≈0.13% | 245 072 | 2026-01-08 |
| MCBRIDE DANIEL G (Chief… | ≈0.09% | 163 848 | 2026-01-08 |
| SHEFFIELD HOLLY R (Offic… | ≈0.02% | 43 261 | 2026-01-08 |
| JAY COLLEEN E (Director) | ≈0.02% | 39 907 | 2026-04-01 |
| KOZY WILLIAM A (Director… | ≈0.02% | 31 149 | 2025-04-01 |
| KURZIUS LAWRENCE ERIK (D… | ≈0.02% | 31 099 | 2026-09-16 |
| ANDREWS BRIAN G (Chief F… | ≈0.02% | 30 728 | 2026-01-08 |
| WARNER GERARD H, III (Of… | ≈0.01% | 23 852 | 2026-01-08 |
| ROSEBROUGH WALTER M JR (… | — | — | 2026-09-14 |
